0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artemisinin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-2305
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Artemisinin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Artemisinin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-2305
Report
May 2025
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artemisinin Market Size

In 2024, the global market size of Artemisinin was estimated to be worth US$ 89 million and is forecast to reach approximately US$ 314 million by 2031 with a CAGR of 20.0% during the forecast period 2025-2031.

Artemisinin Market

Artemisinin Market

Artemisinin is a natural compound extracted from the sweet wormwood plant (Artemisia annua), widely recognized for its potent antimalarial properties. It is effective in rapidly reducing malaria parasite levels in the blood and is a primary component of artemisinin-based combination therapies (ACTs), which are the standard treatment for malaria worldwide. Due to its effectiveness and rapid action, artemisinin has been a critical advancement in global malaria control efforts.
The artemisinin market is driven primarily by the global need to combat malaria, a disease that affects millions, especially in tropical and subtropical regions. As a key ingredient in artemisinin-based combination therapies (ACTs), the standard treatment for malaria, demand for artemisinin remains strong, especially in regions with high malaria prevalence. Increasing global health initiatives and funding from governments and organizations like the World Health Organization (WHO) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria continue to support artemisinin production and distribution. Additionally, advancements in synthetic biology and semi-synthetic production methods are helping to stabilize supply.
The artemisinin market faces challenges such as dependency on seasonal agricultural production from Artemisia annua, which can lead to fluctuations in supply and pricing. Climate variability and agricultural risks can impact the availability and quality of raw material, causing potential shortages. Additionally, resistance to artemisinin is emerging in some regions, particularly in Southeast Asia, raising concerns over the long-term efficacy of artemisinin-based therapies. This resistance is pushing researchers and health organizations to seek alternative treatments, which may impact future demand for artemisinin.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Artemisinin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinin.
The Artemisinin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artemisinin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemisinin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Artemisinin Market Report

Report Metric Details
Report Name Artemisinin Market
Forecasted market size in 2031 approximately US$ 314 million
CAGR 20.0%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, KPC Pharmaceuticals, Kerui nanhai, Guangxi xiancaotang, Fosun Group, Natural Bio-engineering, BIONEXX, CAT KHANH, BEEPZ, Huafang Ketai, Huali Phamra
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Artemisinin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Artemisinin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artemisinin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Artemisinin Market size in 2031?

Ans: The Artemisinin Market size in 2031 will be approximately US$ 314 million.

Who are the main players in the Artemisinin Market report?

Ans: The main players in the Artemisinin Market are Sanofi, KPC Pharmaceuticals, Kerui nanhai, Guangxi xiancaotang, Fosun Group, Natural Bio-engineering, BIONEXX, CAT KHANH, BEEPZ, Huafang Ketai, Huali Phamra

What are the Application segmentation covered in the Artemisinin Market report?

Ans: The Applications covered in the Artemisinin Market report are Antimalarial Injections, Antimalarial Tablets

What are the Type segmentation covered in the Artemisinin Market report?

Ans: The Types covered in the Artemisinin Market report are Extraction From Artemisia Annua, Semisynthetic Artemisinin

Recommended Reports

Herbal and Botanical

Anti-Malarial Drugs

API and Pharmaceutical

Market trends :

Topic Trends
Global the artemisinin market is experiencing rapid growth driven by increased global health initiatives, rising demand for antimalarial therapies, and advancements in semi-synthetic production stabilizing supply.
Type Extraction From Artemisia Annua - market faces supply and pricing fluctuations due to dependency on seasonal agricultural production and climate variability impacting artemisia annua crops.
Semisynthetic Artemisinin - advancements in semi-synthetic artemisinin production are helping stabilize global supply and reduce reliance on agricultural cycles.
Application Antimalarial Injections - demand for antimalarial injections remains strong as artemisinin-based therapies continue to be the standard treatment for malaria worldwide.
Antimalarial Tablets - antimalarial tablets containing artemisinin are widely adopted in malaria-endemic regions due to their efficacy and rapid action.
Region APAC - apac remains a key market due to high malaria prevalence and emerging resistance concerns driving ongoing demand for artemisinin therapies.
EMEA - emea benefits from strong global health funding and initiatives targeting malaria control, supporting artemisinin market growth.
LATAM - latam sees steady demand for artemisinin-based treatments in malaria-affected areas, supported by regional health programs.
North America - north america's artemisinin market is driven by research, development, and global supply chain roles rather than domestic malaria prevalence.
1 Study Coverage
1.1 Artemisinin Product Introduction
1.2 Market by Type
1.2.1 Global Artemisinin Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Extraction From Artemisia Annua
1.2.3 Semisynthetic Artemisinin
1.3 Market by Application
1.3.1 Global Artemisinin Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Antimalarial Injections
1.3.3 Antimalarial Tablets
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Artemisinin Market Size Estimates and Forecasts
2.1.1 Global Artemisinin Revenue 2020-2031
2.1.2 Global Artemisinin Sales 2020-2031
2.2 Artemisinin Market Size by Region: 2024 Versus 2031
2.3 Artemisinin Sales by Region (2020-2031)
2.3.1 Global Artemisinin Sales by Region: 2020-2025
2.3.2 Global Artemisinin Sales Forecast by Region (2026-2031)
2.3.3 Global Artemisinin Sales Market Share by Region (2020-2031)
2.4 Artemisinin Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Artemisinin Revenue by Region: 2020-2025
2.4.2 Global Artemisinin Revenue Forecast by Region (2026-2031)
2.4.3 Global Artemisinin Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Artemisinin Sales by Type (2020-2031)
3.1.1.1 Global Artemisinin Sales Volume by Type (2020-2031)
3.1.1.2 Global Artemisinin Sales Market Share by Type (2020-2031)
3.1.2 Global Artemisinin Revenue by Type (2020-2031)
3.1.2.1 Global Artemisinin Revenue by Type (2020-2031)
3.1.2.2 Global Artemisinin Revenue Market Share by Type (2020-2031)
3.1.3 Artemisinin Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Artemisinin Sales by Application (2020-2031)
3.2.1.1 Global Artemisinin Sales Volume by Application (2020-2031)
3.2.1.2 Global Artemisinin Sales Market Share by Application (2020-2031)
3.2.2 Global Artemisinin Revenue by Application (2020-2031)
3.2.2.1 Global Artemisinin Revenue by Application (2020-2031)
3.2.2.2 Global Artemisinin Revenue Market Share by Application (2020-2031)
3.2.3 Artemisinin Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Extraction From Artemisia Annua of Artemisinin Revenue Market Share by Application
3.3.2 Semisynthetic Artemisinin of Artemisinin Revenue Market Share by Application
4 Global Artemisinin by Manufacturers
4.1 Global Top Artemisinin Manufacturers by Sales (2020-2025)
4.1.1 Global Artemisinin Sales by Manufacturer (2020-2025)
4.1.2 Global Artemisinin Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Artemisinin Manufacturers by Revenue (2020-2025)
4.2.1 Global Artemisinin Revenue by Manufacturer (2020-2025)
4.2.2 Global Artemisinin Revenue Share by Manufacturer (2020-2025)
4.3 Global Artemisinin Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Artemisinin Manufacturers Covered: Ranking by Revenue
4.4.2 Global Artemisinin Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Artemisinin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Artemisinin Manufacturing Base Distribution, Product Type
4.5.1 Artemisinin Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Artemisinin Market
4.5.3 Manufacturers Artemisinin Product Type and Application
4.5.4 Extraction From Artemisia Annua Market Sales of Artemisinin by Manufacturer
4.5.5 Semisynthetic Artemisinin Market Sales of Artemisinin by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sanofi
5.1.1 Sanofi Company Information
5.1.2 Sanofi Description, Business Overview
5.1.3 Sanofi Artemisinin Products Offered
5.1.4 Sanofi Artemisinin Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Sanofi Artemisinin Sales by Product in 2024
5.1.6 Sanofi Artemisinin Sales by Application in 2024
5.1.7 Sanofi Artemisinin Sales by Geographic Area in 2024
5.1.8 Sanofi Recent Developments
5.2 KPC Pharmaceuticals
5.2.1 KPC Pharmaceuticals Company Information
5.2.2 KPC Pharmaceuticals Description, Business Overview
5.2.3 KPC Pharmaceuticals Artemisinin Products Offered
5.2.4 KPC Pharmaceuticals Artemisinin Sales, Revenue and Gross Margin (2020-2025)
5.2.5 KPC Pharmaceuticals Artemisinin Sales by Product in 2024
5.2.6 KPC Pharmaceuticals Artemisinin Sales by Application in 2024
5.2.7 KPC Pharmaceuticals Artemisinin Sales by Geographic Area in 2024
5.2.8 KPC Pharmaceuticals Recent Developments
5.3 Kerui nanhai
5.3.1 Kerui nanhai Company Information
5.3.2 Kerui nanhai Description, Business Overview
5.3.3 Kerui nanhai Artemisinin Products Offered
5.3.4 Kerui nanhai Artemisinin Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Kerui nanhai Artemisinin Sales by Product in 2024
5.3.6 Kerui nanhai Artemisinin Sales by Application in 2024
5.3.7 Kerui nanhai Artemisinin Sales by Geographic Area in 2024
5.3.8 Kerui nanhai Recent Developments
5.4 Guangxi xiancaotang
5.4.1 Guangxi xiancaotang Company Information
5.4.2 Guangxi xiancaotang Description, Business Overview
5.4.3 Guangxi xiancaotang Artemisinin Products Offered
5.4.4 Guangxi xiancaotang Artemisinin Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Guangxi xiancaotang Artemisinin Sales by Product in 2024
5.4.6 Guangxi xiancaotang Artemisinin Sales by Application in 2024
5.4.7 Guangxi xiancaotang Artemisinin Sales by Geographic Area in 2024
5.4.8 Guangxi xiancaotang Recent Developments
5.5 Fosun Group
5.5.1 Fosun Group Company Information
5.5.2 Fosun Group Description, Business Overview
5.5.3 Fosun Group Artemisinin Products Offered
5.5.4 Fosun Group Artemisinin Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Fosun Group Artemisinin Sales by Product in 2024
5.5.6 Fosun Group Artemisinin Sales by Application in 2024
5.5.7 Fosun Group Artemisinin Sales by Geographic Area in 2024
5.5.8 Fosun Group Recent Developments
5.6 Natural Bio-engineering
5.6.1 Natural Bio-engineering Company Information
5.6.2 Natural Bio-engineering Description, Business Overview
5.6.3 Natural Bio-engineering Artemisinin Products Offered
5.6.4 Natural Bio-engineering Artemisinin Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Natural Bio-engineering Artemisinin Sales by Product in 2024
5.6.6 Natural Bio-engineering Artemisinin Sales by Application in 2024
5.6.7 Natural Bio-engineering Artemisinin Sales by Geographic Area in 2024
5.6.8 Natural Bio-engineering Recent Developments
5.7 BIONEXX
5.7.1 BIONEXX Company Information
5.7.2 BIONEXX Description, Business Overview
5.7.3 BIONEXX Artemisinin Products Offered
5.7.4 BIONEXX Artemisinin Sales, Revenue and Gross Margin (2020-2025)
5.7.5 BIONEXX Artemisinin Sales by Product in 2024
5.7.6 BIONEXX Artemisinin Sales by Application in 2024
5.7.7 BIONEXX Artemisinin Sales by Geographic Area in 2024
5.7.8 BIONEXX Recent Developments
5.8 CAT KHANH
5.8.1 CAT KHANH Company Information
5.8.2 CAT KHANH Description, Business Overview
5.8.3 CAT KHANH Artemisinin Products Offered
5.8.4 CAT KHANH Artemisinin Sales, Revenue and Gross Margin (2020-2025)
5.8.5 CAT KHANH Artemisinin Sales by Product in 2024
5.8.6 CAT KHANH Artemisinin Sales by Application in 2024
5.8.7 CAT KHANH Artemisinin Sales by Geographic Area in 2024
5.8.8 CAT KHANH Recent Developments
5.9 BEEPZ
5.9.1 BEEPZ Company Information
5.9.2 BEEPZ Description, Business Overview
5.9.3 BEEPZ Artemisinin Products Offered
5.9.4 BEEPZ Artemisinin Sales, Revenue and Gross Margin (2020-2025)
5.9.5 BEEPZ Artemisinin Sales by Product in 2024
5.9.6 BEEPZ Artemisinin Sales by Application in 2024
5.9.7 BEEPZ Artemisinin Sales by Geographic Area in 2024
5.9.8 BEEPZ Recent Developments
5.10 Huafang Ketai
5.10.1 Huafang Ketai Company Information
5.10.2 Huafang Ketai Description, Business Overview
5.10.3 Huafang Ketai Artemisinin Products Offered
5.10.4 Huafang Ketai Artemisinin Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Huafang Ketai Artemisinin Sales by Product in 2024
5.10.6 Huafang Ketai Artemisinin Sales by Application in 2024
5.10.7 Huafang Ketai Artemisinin Sales by Geographic Area in 2024
5.10.8 Huafang Ketai Recent Developments
5.11 Huali Phamra
5.11.1 Huali Phamra Company Information
5.11.2 Huali Phamra Description, Business Overview
5.11.3 Huali Phamra Artemisinin Products Offered
5.11.4 Huali Phamra Artemisinin Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Huali Phamra Artemisinin Sales by Product in 2024
5.11.6 Huali Phamra Artemisinin Sales by Application in 2024
5.11.7 Huali Phamra Artemisinin Sales by Geographic Area in 2024
5.11.8 Huali Phamra Recent Developments
6 North America
6.1 North America Artemisinin Market Size YoY Growth 2020-2031
6.2 North America Artemisinin Market Facts & Figures by Country
6.2.1 North America Artemisinin Sales by Country (2020-2031)
6.2.2 North America Artemisinin Revenue by Country (2020-2031)
6.3 North America Artemisinin Sales by Type (2020-2025)
6.4 North America Artemisinin Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Artemisinin Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Artemisinin Market Facts & Figures by Region
7.2.1 Asia-Pacific Artemisinin Sales by Region (2020-2031)
7.2.2 Asia-Pacific Artemisinin Revenue by Region (2020-2031)
7.3 Asia-Pacific Artemisinin Sales by Type (2020-2025)
7.4 Asia-Pacific Artemisinin Sales by Application (2020-2025)
8 Europe
8.1 Europe Artemisinin Market Size YoY Growth 2020-2031
8.2 Europe Artemisinin Market Facts & Figures by Country
8.2.1 Europe Artemisinin Sales by Country (2020-2031)
8.2.2 Europe Artemisinin Revenue by Country (2020-2031)
8.3 Europe Artemisinin Sales by Type (2020-2025)
8.4 Europe Artemisinin Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Artemisinin Market Size YoY Growth 2020-2031
9.2 Latin America Artemisinin Market Facts & Figures by Country
9.2.1 Latin America Artemisinin Sales by Country (2020-2031)
9.2.2 Latin America Artemisinin Revenue by Country (2020-2031)
9.3 Latin America Artemisinin Sales by Type (2020-2025)
9.4 Latin America Artemisinin Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Artemisinin Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Artemisinin Market Facts & Figures by Country
10.2.1 Middle East and Africa Artemisinin Sales by Country (2020-2031)
10.2.2 Middle East and Africa Artemisinin Revenue by Country (2020-2031)
10.3 Middle East and Africa Artemisinin Sales by Type (2020-2025)
10.4 Middle East and Africa Artemisinin Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Artemisinin Supply Chain Analysis
11.2 Artemisinin Key Raw Materials and Upstream Suppliers
11.3 Artemisinin Clients Analysis
11.4 Artemisinin Sales Channel and Sales Model Analysis
11.4.1 Artemisinin Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Artemisinin Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Artemisinin Distributors
12 Artemisinin Market Dynamics
12.1 Artemisinin Industry Trends
12.2 Artemisinin Market Drivers
12.3 Artemisinin Market Challenges
12.4 Artemisinin Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Artemisinin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Artemisinin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Artemisinin Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Artemisinin Sales by Region (2020-2025) & (MT)
 Table 5. Global Artemisinin Sales Forecast by Region (2026-2031) & (MT)
 Table 6. Global Artemisinin Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Artemisinin Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Artemisinin Sales Volume by Type (2020-2025) & (MT)
 Table 9. Global Artemisinin Sales Volume by Type (2026-2031) & (MT)
 Table 10. Global Artemisinin Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Artemisinin Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Artemisinin Sales Volume by Application (2020-2025) & (MT)
 Table 13. Global Artemisinin Sales Volume by Application (2026-2031) & (MT)
 Table 14. Global Artemisinin Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Artemisinin Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Artemisinin Sales by Manufacturer (2020-2025) & (MT)
 Table 17. Global Artemisinin Sales Share by Manufacturer (2020-2025)
 Table 18. Artemisinin Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Artemisinin Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Artemisinin Price (2020-2025) & (USD/MT)
 Table 21. Ranking of Global Top Artemisinin Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Artemisinin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Artemisinin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin as of 2024)
 Table 24. Artemisinin Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Artemisinin Market
 Table 26. Manufacturers Artemisinin Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Sanofi Company Information
 Table 29. Sanofi Description and Business Overview
 Table 30. Sanofi Artemisinin Product
 Table 31. Sanofi Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 32. Sanofi Sales Proportion of Artemisinin by Product in 2024
 Table 33. Sanofi Sales Proportion of Artemisinin by Application in 2024
 Table 34. Sanofi Sales Proportion of Artemisinin by Geographic Area in 2024
 Table 35. Sanofi Recent Developments
 Table 36. KPC Pharmaceuticals Company Information
 Table 37. KPC Pharmaceuticals Description and Business Overview
 Table 38. KPC Pharmaceuticals Artemisinin Product
 Table 39. KPC Pharmaceuticals Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 40. KPC Pharmaceuticals Sales Proportion of Artemisinin by Product in 2024
 Table 41. KPC Pharmaceuticals Sales Proportion of Artemisinin by Application in 2024
 Table 42. KPC Pharmaceuticals Sales Proportion of Artemisinin by Geographic Area in 2024
 Table 43. KPC Pharmaceuticals Recent Developments
 Table 44. Kerui nanhai Company Information
 Table 45. Kerui nanhai Description and Business Overview
 Table 46. Kerui nanhai Artemisinin Product
 Table 47. Kerui nanhai Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 48. Kerui nanhai Sales Proportion of Artemisinin by Product in 2024
 Table 49. Kerui nanhai Sales Proportion of Artemisinin by Application in 2024
 Table 50. Kerui nanhai Sales Proportion of Artemisinin by Geographic Area in 2024
 Table 51. Kerui nanhai Recent Developments
 Table 52. Guangxi xiancaotang Company Information
 Table 53. Guangxi xiancaotang Description and Business Overview
 Table 54. Guangxi xiancaotang Artemisinin Product
 Table 55. Guangxi xiancaotang Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 56. Guangxi xiancaotang Sales Proportion of Artemisinin by Product in 2024
 Table 57. Guangxi xiancaotang Sales Proportion of Artemisinin by Application in 2024
 Table 58. Guangxi xiancaotang Sales Proportion of Artemisinin by Geographic Area in 2024
 Table 59. Guangxi xiancaotang Recent Developments
 Table 60. Fosun Group Company Information
 Table 61. Fosun Group Description and Business Overview
 Table 62. Fosun Group Artemisinin Product
 Table 63. Fosun Group Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 64. Fosun Group Sales Proportion of Artemisinin by Product in 2024
 Table 65. Fosun Group Sales Proportion of Artemisinin by Application in 2024
 Table 66. Fosun Group Sales Proportion of Artemisinin by Geographic Area in 2024
 Table 67. Fosun Group Recent Developments
 Table 68. Natural Bio-engineering Company Information
 Table 69. Natural Bio-engineering Description and Business Overview
 Table 70. Natural Bio-engineering Artemisinin Product
 Table 71. Natural Bio-engineering Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 72. Natural Bio-engineering Sales Proportion of Artemisinin by Product in 2024
 Table 73. Natural Bio-engineering Sales Proportion of Artemisinin by Application in 2024
 Table 74. Natural Bio-engineering Sales Proportion of Artemisinin by Geographic Area in 2024
 Table 75. Natural Bio-engineering Recent Developments
 Table 76. BIONEXX Company Information
 Table 77. BIONEXX Description and Business Overview
 Table 78. BIONEXX Artemisinin Product
 Table 79. BIONEXX Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 80. BIONEXX Sales Proportion of Artemisinin by Product in 2024
 Table 81. BIONEXX Sales Proportion of Artemisinin by Application in 2024
 Table 82. BIONEXX Sales Proportion of Artemisinin by Geographic Area in 2024
 Table 83. BIONEXX Recent Developments
 Table 84. CAT KHANH Company Information
 Table 85. CAT KHANH Description and Business Overview
 Table 86. CAT KHANH Artemisinin Product
 Table 87. CAT KHANH Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. CAT KHANH Sales Proportion of Artemisinin by Product in 2024
 Table 89. CAT KHANH Sales Proportion of Artemisinin by Application in 2024
 Table 90. CAT KHANH Sales Proportion of Artemisinin by Geographic Area in 2024
 Table 91. CAT KHANH Recent Developments
 Table 92. BEEPZ Company Information
 Table 93. BEEPZ Description and Business Overview
 Table 94. BEEPZ Artemisinin Product
 Table 95. BEEPZ Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 96. BEEPZ Sales Proportion of Artemisinin by Product in 2024
 Table 97. BEEPZ Sales Proportion of Artemisinin by Application in 2024
 Table 98. BEEPZ Sales Proportion of Artemisinin by Geographic Area in 2024
 Table 99. BEEPZ Recent Developments
 Table 100. Huafang Ketai Company Information
 Table 101. Huafang Ketai Description and Business Overview
 Table 102. Huafang Ketai Artemisinin Product
 Table 103. Huafang Ketai Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 104. Huafang Ketai Sales Proportion of Artemisinin by Product in 2024
 Table 105. Huafang Ketai Sales Proportion of Artemisinin by Application in 2024
 Table 106. Huafang Ketai Sales Proportion of Artemisinin by Geographic Area in 2024
 Table 107. Huafang Ketai Recent Developments
 Table 108. Huali Phamra Company Information
 Table 109. Huali Phamra Description and Business Overview
 Table 110. Huali Phamra Artemisinin Product
 Table 111. Huali Phamra Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 112. Huali Phamra Sales Proportion of Artemisinin by Product in 2024
 Table 113. Huali Phamra Sales Proportion of Artemisinin by Application in 2024
 Table 114. Huali Phamra Sales Proportion of Artemisinin by Geographic Area in 2024
 Table 115. Huali Phamra Recent Developments
 Table 116. North America Artemisinin Sales by Country (2020-2025) & (MT)
 Table 117. North America Artemisinin Sales by Country (2026-2031) & (MT)
 Table 118. North America Artemisinin Revenue by Country (2020-2025) & (US$ Million)
 Table 119. North America Artemisinin Revenue by Country (2026-2031) & (US$ Million)
 Table 120. North America Artemisinin Sales by Type (2020-2025) & (MT)
 Table 121. North America Artemisinin Sales by Application (2020-2025) & (MT)
 Table 122. Asia-Pacific Artemisinin Sales by Region (2020-2025) & (MT)
 Table 123. Asia-Pacific Artemisinin Sales by Region (2026-2031) & (MT)
 Table 124. Asia-Pacific Artemisinin Revenue by Region (2020-2025) & (US$ Million)
 Table 125. Asia-Pacific Artemisinin Revenue by Region (2026-2031) & (US$ Million)
 Table 126. Asia-Pacific Artemisinin Sales by Type (2020-2025) & (MT)
 Table 127. Asia-Pacific Artemisinin Sales by Application (2020-2025) & (MT)
 Table 128. Europe Artemisinin Sales by Country (2020-2025) & (MT)
 Table 129. Europe Artemisinin Sales by Country (2026-2031) & (MT)
 Table 130. Europe Artemisinin Revenue by Country (2020-2025) & (US$ Million)
 Table 131. Europe Artemisinin Revenue by Country (2026-2031) & (US$ Million)
 Table 132. Europe Artemisinin Sales by Type (2020-2025) & (MT)
 Table 133. Europe Artemisinin Sales by Application (2020-2025) & (MT)
 Table 134. Latin America Artemisinin Sales by Country (2020-2025) & (MT)
 Table 135. Latin America Artemisinin Sales by Country (2026-2031) & (MT)
 Table 136. Latin America Artemisinin Revenue by Country (2020-2025) & (US$ Million)
 Table 137. Latin America Artemisinin Revenue by Country (2026-2031) & (US$ Million)
 Table 138. Latin America Artemisinin Sales by Type (2020-2025) & (MT)
 Table 139. Latin America Artemisinin Sales by Application (2020-2025) & (MT)
 Table 140. Middle East and Africa Artemisinin Sales by Country (2020-2025) & (MT)
 Table 141. Middle East and Africa Artemisinin Sales by Country (2026-2031) & (MT)
 Table 142. Middle East and Africa Artemisinin Revenue by Country (2020-2025) & (US$ Million)
 Table 143. Middle East and Africa Artemisinin Revenue by Country (2026-2031) & (US$ Million)
 Table 144. Middle East and Africa Artemisinin Sales by Type (2020-2025) & (MT)
 Table 145. Middle East and Africa Artemisinin Sales by Application (2020-2025) & (MT)
 Table 146. Artemisinin Key Raw Materials, Industry Status and Trend
 Table 147. Artemisinin Key Raw Materials and Upstream Suppliers
 Table 148. Artemisinin Clients Status and Trend
 Table 149. Artemisinin Typical Clients
 Table 150. Artemisinin Distributors
 Table 151. Artemisinin Market Trends
 Table 152. Artemisinin Market Drivers
 Table 153. Artemisinin Market Challenges
 Table 154. Artemisinin Market Restraints
 Table 155. Research Programs/Design for This Report
 Table 156. Key Data Information from Secondary Sources
 Table 157. Key Data Information from Primary Sources
 Table 158. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Artemisinin Product Picture
 Figure 2. Global Artemisinin Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Artemisinin Sales Market Share by Type in 2024 & 2031
 Figure 4. Extraction From Artemisia Annua Product Picture
 Figure 5. Semisynthetic Artemisinin Product Picture
 Figure 6. Global Artemisinin Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Artemisinin Sales Market Share by Application in 2024 & 2031
 Figure 8. Antimalarial Injections
 Figure 9. Antimalarial Tablets
 Figure 10. Artemisinin Report Years Considered
 Figure 11. Global Artemisinin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Artemisinin Market Size 2020-2031 (US$ Million)
 Figure 13. Global Artemisinin Sales 2020-2031 (MT)
 Figure 14. Global Artemisinin Sales Market Share Forecast by Region (2020-2031)
 Figure 15. Global Artemisinin Revenue Market Share by Region (2020-2031)
 Figure 16. Global Artemisinin Sales Market Share Forecast by Type (2020-2031)
 Figure 17. Global Artemisinin Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Artemisinin Average Selling Price (ASP) by Type (2020-2025) & (USD/MT)
 Figure 19. Global Artemisinin Sales Market Share Forecast by Application (2020-2031)
 Figure 20. Global Artemisinin Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. Artemisinin Average Selling Price (ASP) by Application (2020-2025) & (USD/MT)
 Figure 22. Extraction From Artemisia Annua of Artemisinin Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Semisynthetic Artemisinin of Artemisinin Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Global Artemisinin Sales Share by Manufacturer in 2024
 Figure 25. Artemisinin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Extraction From Artemisia Annua Market Sales Proportion by Manufacturer in 2024
 Figure 27. Semisynthetic Artemisinin Market Sales Proportion by Manufacturer in 2024
 Figure 28. North America Artemisinin Revenue 2020-2031 (US$ Million)
 Figure 29. North America Artemisinin Sales Market Share by Type (2020-2025)
 Figure 30. North America Artemisinin Sales Market Share by Application (2020-2025)
 Figure 31. Asia-Pacific Artemisinin Revenue 2020-2031 (US$ Million)
 Figure 32. Asia-Pacific Artemisinin Sales Market Share by Region (2020-2031)
 Figure 33. Asia-Pacific Artemisinin Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Artemisinin Sales Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific Artemisinin Sales Market Share by Application (2020-2025)
 Figure 36. Europe Artemisinin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe Artemisinin Sales Market Share by Country (2020-2031)
 Figure 38. Europe Artemisinin Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Artemisinin Sales Market Share by Type (2020-2025)
 Figure 40. Europe Artemisinin Sales Market Share by Application (2020-2025)
 Figure 41. Latin America Artemisinin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Artemisinin Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Artemisinin Revenue Market Share by Country (2020-2025)
 Figure 44. Latin America Artemisinin Sales Market Share by Type (2020-2025)
 Figure 45. Latin America Artemisinin Sales Market Share by Application (2020-2025)
 Figure 46. Middle East and Africa Artemisinin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Middle East and Africa Artemisinin Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Artemisinin Revenue Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Artemisinin Sales Market Share by Type (2020-2025)
 Figure 50. Middle East and Africa Artemisinin Sales Market Share by Application (2020-2025)
 Figure 51. Artemisinin Supply Chain (Upstream and Downstream Market)
 Figure 52. Global Production Market Share of Artemisinin Raw Materials by Region in 2024
 Figure 53. Artemisinin Distribution Channels
 Figure 54. Global Artemisinin Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 55. Global Artemisinin Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS